Inhibrx Biosciences
INBX
#6080
Rank
NZ$1.86 B
Marketcap
NZ$126.08
Share price
-7.21%
Change (1 day)
-15.65%
Change (1 year)

Inhibrx Biosciences (INBX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$0.37 Billion

According to Inhibrx Biosciences's latest financial reports the company's total liabilities are NZ$0.37 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inhibrx Biosciences - Total liabilities on balance sheet (from 2023 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.23 B185.81%
2024-12-31NZ$83.66 M-79.99%
2023-12-31NZ$0.41 B1008.52%
2022-12-31NZ$37.71 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$42.82 M-88.69%๐Ÿ‡บ๐Ÿ‡ธ USA